News

Extendicare Announces Timing of 2023 Third Quarter Results and Conference Call

MARKHAM, Ontario, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it…

2 years ago

Lowell Farms Inc. Announces Repurchase of $22 Million of Senior Secured Convertible Debentures

California cannabis leader repurchases all outstanding senior secured convertible indebtednessSALINAS, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Lowell Farms Inc.…

2 years ago

LSL Pharma Group Engages Paradox as Investor Relations Services Provider

BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma…

2 years ago

Applied UV to Introduce Airocide® Pro+ Air Food Preservation Solution Designed to Control Ethylene Levels and Extend Shelf Life at the Global Produce & Floral Show, Together With Canon Virginia, a Subsidiary of Canon U.S.A.

Applied UV, Inc. Airocide® Pro+ Applications Across the Food Supply and Logistics ChainRemoving Ethylene, a Gas Produced Naturally, is Critical…

2 years ago

Immunocore announces upcoming presentation and posters at ESMO 2023

Immunocore announces upcoming presentation and posters at ESMO 2023 Long-term survival data for KIMMTRAK in previously untreated patients with metastatic…

2 years ago

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

LONDON and SALT LAKE CITY, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company…

2 years ago

The Ensign Group Acquires Skilled Nursing Facility in Kansas

SAN JUAN CAPISTRANO, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group…

2 years ago

Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023

LONDON and RALEIGH, N.C., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”),…

2 years ago

Spexis to host business update conference call on October 9, 2023

ALLSCHWIL, Switzerland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics…

2 years ago